JP2020504186A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020504186A5 JP2020504186A5 JP2019557681A JP2019557681A JP2020504186A5 JP 2020504186 A5 JP2020504186 A5 JP 2020504186A5 JP 2019557681 A JP2019557681 A JP 2019557681A JP 2019557681 A JP2019557681 A JP 2019557681A JP 2020504186 A5 JP2020504186 A5 JP 2020504186A5
- Authority
- JP
- Japan
- Prior art keywords
- acetonitrile
- cyclohexyl
- pyridin
- imidazole
- hydroxyethyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims 33
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 claims 20
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims 11
- 150000001875 compounds Chemical class 0.000 claims 10
- 150000002460 imidazoles Chemical class 0.000 claims 9
- 150000003839 salts Chemical class 0.000 claims 8
- 125000000250 methylamino group Chemical group [H]N(*)C([H])([H])[H] 0.000 claims 7
- 239000008194 pharmaceutical composition Substances 0.000 claims 5
- 239000012453 solvate Substances 0.000 claims 5
- YZCKVEUIGOORGS-OUBTZVSYSA-N Deuterium Chemical group [2H] YZCKVEUIGOORGS-OUBTZVSYSA-N 0.000 claims 4
- 229910052805 deuterium Inorganic materials 0.000 claims 4
- 125000004066 1-hydroxyethyl group Chemical group [H]OC([H])([*])C([H])([H])[H] 0.000 claims 3
- 125000000217 alkyl group Chemical group 0.000 claims 3
- 201000010099 disease Diseases 0.000 claims 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 3
- 229910052739 hydrogen Inorganic materials 0.000 claims 3
- 239000001257 hydrogen Substances 0.000 claims 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 2
- 210000000987 immune system Anatomy 0.000 claims 2
- 230000002265 prevention Effects 0.000 claims 2
- 125000001424 substituent group Chemical group 0.000 claims 2
- 208000023275 Autoimmune disease Diseases 0.000 claims 1
- 206010012438 Dermatitis atopic Diseases 0.000 claims 1
- 101000997835 Homo sapiens Tyrosine-protein kinase JAK1 Proteins 0.000 claims 1
- PQHPWXJREYZBAC-MGCOHNPYSA-N NC=1C(=CC(=NC=1)Cl)N[C@@H]1CC[C@H](CC1)CC#N Chemical group NC=1C(=CC(=NC=1)Cl)N[C@@H]1CC[C@H](CC1)CC#N PQHPWXJREYZBAC-MGCOHNPYSA-N 0.000 claims 1
- 102100033438 Tyrosine-protein kinase JAK1 Human genes 0.000 claims 1
- 201000008937 atopic dermatitis Diseases 0.000 claims 1
- 125000004093 cyano group Chemical group *C#N 0.000 claims 1
- 230000003831 deregulation Effects 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 1
- 230000005764 inhibitory process Effects 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17151020.9 | 2017-01-11 | ||
| EP17151020 | 2017-01-11 | ||
| PCT/EP2018/050548 WO2018130563A1 (en) | 2017-01-11 | 2018-01-10 | Novel amino-imidazopyridine derivatives as janus kinase inhibitors and pharmaceutical use thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020504186A JP2020504186A (ja) | 2020-02-06 |
| JP2020504186A5 true JP2020504186A5 (OSRAM) | 2021-02-12 |
| JP7009504B2 JP7009504B2 (ja) | 2022-01-25 |
Family
ID=57777557
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019557681A Active JP7009504B2 (ja) | 2017-01-11 | 2018-01-10 | ヤヌスキナーゼ阻害剤としての新規アミノイミダゾピリジン誘導体及びそれらの医薬としての使用 |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US10703751B2 (OSRAM) |
| EP (1) | EP3568396B1 (OSRAM) |
| JP (1) | JP7009504B2 (OSRAM) |
| KR (1) | KR102548543B1 (OSRAM) |
| CN (1) | CN110167938B (OSRAM) |
| AU (1) | AU2018208516B2 (OSRAM) |
| CA (1) | CA3045567A1 (OSRAM) |
| CY (1) | CY1123864T1 (OSRAM) |
| DK (1) | DK3568396T3 (OSRAM) |
| ES (1) | ES2846741T3 (OSRAM) |
| HR (1) | HRP20210095T1 (OSRAM) |
| HU (1) | HUE052720T2 (OSRAM) |
| IL (1) | IL267829B (OSRAM) |
| LT (1) | LT3568396T (OSRAM) |
| MX (1) | MX389378B (OSRAM) |
| MY (1) | MY195576A (OSRAM) |
| NZ (1) | NZ754922A (OSRAM) |
| PL (1) | PL3568396T3 (OSRAM) |
| PT (1) | PT3568396T (OSRAM) |
| RS (1) | RS61317B1 (OSRAM) |
| RU (1) | RU2019125177A (OSRAM) |
| SI (1) | SI3568396T1 (OSRAM) |
| TW (1) | TWI760419B (OSRAM) |
| UA (1) | UA123972C2 (OSRAM) |
| WO (1) | WO2018130563A1 (OSRAM) |
| ZA (1) | ZA201904190B (OSRAM) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JOP20190144A1 (ar) | 2016-12-16 | 2019-06-16 | Janssen Pharmaceutica Nv | إيميدازو بيرولو بيريدين كمثبطات لعائلة jak الخاصة بإنزيمات الكيناز |
| PL3555097T3 (pl) | 2016-12-16 | 2022-10-17 | Janssen Pharmaceutica Nv | Związki imidazo[4,5-d]pirolo[2,3-b]pirydynowe jako inhibitory kinaz janusowych |
| TW202016110A (zh) | 2018-06-15 | 2020-05-01 | 比利時商健生藥品公司 | Ｊａｋ激酶家族之小分子抑制劑 |
| WO2020007698A1 (en) * | 2018-07-06 | 2020-01-09 | Leo Pharma A/S | Novel amino-imidazopyrimidine derivatives as janus kinase inhibitors and pharmaceutical use thereof |
| JP7345220B2 (ja) * | 2019-08-30 | 2023-09-15 | ティーエスディー ライフ サイエンス カンパニー リミテッド | イミダゾピリジン誘導体及びこれを有効成分として含有する薬学的組成物 |
| BR112023018286A2 (pt) | 2021-03-11 | 2023-10-31 | Janssen Pharmaceutica Nv | Lorpucitinib para uso no tratamento de distúrbios mediados por jak |
| CN119569971B (zh) * | 2025-02-07 | 2025-05-27 | 吉林大学 | 一种用于蛋白质磷酸化和棕榈酰化修饰同时筛选的Janus材料的制备方法 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8389527B2 (en) * | 2008-02-06 | 2013-03-05 | Bristol-Myers Squibb Company | Substituted imidazopyridazines useful as kinase inhibitors |
| EP2523957A1 (en) * | 2010-01-12 | 2012-11-21 | F. Hoffmann-La Roche AG | Tricyclic heterocyclic compounds, compositions and methods of use thereof |
| RU2013109143A (ru) * | 2010-08-05 | 2014-09-10 | Амджен Инк. | Бензимидазол- и азабензимидазолсодержащие соединения, которые ингибируют киназу анапластической лимфомы |
| EP2518071A1 (en) * | 2011-04-29 | 2012-10-31 | Almirall, S.A. | Imidazopyridine derivatives as PI3K inhibitors |
| EP2527344A1 (en) * | 2011-05-25 | 2012-11-28 | Almirall, S.A. | Pyridin-2(1H)-one derivatives useful as medicaments for the treatment of myeloproliferative disorders, transplant rejection, immune-mediated and inflammatory diseases |
| WO2013007768A1 (en) * | 2011-07-13 | 2013-01-17 | F. Hoffmann-La Roche Ag | Tricyclic heterocyclic compounds, compositions and methods of use thereof as jak inhibitors |
| WO2013007765A1 (en) | 2011-07-13 | 2013-01-17 | F. Hoffmann-La Roche Ag | Fused tricyclic compounds for use as inhibitors of janus kinases |
| UY34616A (es) * | 2012-02-10 | 2013-09-30 | Galapagos Nv | Nuevo compuesto útil para el tratamiento de enfermedades degenerativas e inflamatorias. |
| BR112015009942A2 (pt) | 2012-11-01 | 2017-07-11 | Incyte Corp | derivados de tiofeno fundidos tricíclicos como inibidores de jak |
| WO2014081718A1 (en) * | 2012-11-20 | 2014-05-30 | Genentech, Inc. | Aminopyrimidine compounds as inhibitors of t790m containing egfr mutants |
| CN104098563A (zh) * | 2013-04-02 | 2014-10-15 | 山东亨利医药科技有限责任公司 | Jnk抑制剂化合物 |
| SG11201609016VA (en) * | 2014-04-30 | 2016-11-29 | Incyte Corp | Processes of preparing a jak1 inhibitor and new forms thereto |
| EA201990523A1 (ru) * | 2016-10-03 | 2019-10-31 | НОВЫЕ СЕЛЕКТИВНЫЕ ИНГИБИТОРЫ Jak1 И ИХ ПРИМЕНЕНИЕ | |
| JOP20190144A1 (ar) * | 2016-12-16 | 2019-06-16 | Janssen Pharmaceutica Nv | إيميدازو بيرولو بيريدين كمثبطات لعائلة jak الخاصة بإنزيمات الكيناز |
-
2018
- 2018-01-10 UA UAA201908568A patent/UA123972C2/uk unknown
- 2018-01-10 SI SI201830191T patent/SI3568396T1/sl unknown
- 2018-01-10 DK DK18702412.0T patent/DK3568396T3/da active
- 2018-01-10 EP EP18702412.0A patent/EP3568396B1/en active Active
- 2018-01-10 MX MX2019008331A patent/MX389378B/es unknown
- 2018-01-10 RS RS20210044A patent/RS61317B1/sr unknown
- 2018-01-10 RU RU2019125177A patent/RU2019125177A/ru unknown
- 2018-01-10 CA CA3045567A patent/CA3045567A1/en active Pending
- 2018-01-10 PL PL18702412T patent/PL3568396T3/pl unknown
- 2018-01-10 HU HUE18702412A patent/HUE052720T2/hu unknown
- 2018-01-10 US US16/477,249 patent/US10703751B2/en active Active
- 2018-01-10 PT PT187024120T patent/PT3568396T/pt unknown
- 2018-01-10 NZ NZ754922A patent/NZ754922A/en unknown
- 2018-01-10 CN CN201880006261.0A patent/CN110167938B/zh active Active
- 2018-01-10 AU AU2018208516A patent/AU2018208516B2/en active Active
- 2018-01-10 MY MYPI2019003964A patent/MY195576A/en unknown
- 2018-01-10 JP JP2019557681A patent/JP7009504B2/ja active Active
- 2018-01-10 KR KR1020197021697A patent/KR102548543B1/ko active Active
- 2018-01-10 ES ES18702412T patent/ES2846741T3/es active Active
- 2018-01-10 WO PCT/EP2018/050548 patent/WO2018130563A1/en not_active Ceased
- 2018-01-10 HR HRP20210095TT patent/HRP20210095T1/hr unknown
- 2018-01-10 LT LTEP18702412.0T patent/LT3568396T/lt unknown
- 2018-01-11 TW TW107101035A patent/TWI760419B/zh active
-
2019
- 2019-06-26 ZA ZA2019/04190A patent/ZA201904190B/en unknown
- 2019-07-03 IL IL267829A patent/IL267829B/en unknown
-
2021
- 2021-02-01 CY CY20211100085T patent/CY1123864T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020504186A5 (OSRAM) | ||
| AU2023201399B2 (en) | Modulators of the integrated stress pathway | |
| JP2014513110A5 (OSRAM) | ||
| TWI810582B (zh) | 酪胺酸激酶抑制劑 | |
| JP2020183410A5 (OSRAM) | ||
| JP2017526726A5 (OSRAM) | ||
| JP2014511893A5 (OSRAM) | ||
| JP2020505395A5 (OSRAM) | ||
| JP2017509689A5 (OSRAM) | ||
| JP2016527238A5 (OSRAM) | ||
| JP2013542256A5 (OSRAM) | ||
| JP2014139226A5 (OSRAM) | ||
| JP2013515074A5 (OSRAM) | ||
| RU2019125177A (ru) | Новые производные амино-имидазопиридина в качестве ингибиторов янус-киназы и их фармацевтическое применение | |
| JP2018537535A5 (OSRAM) | ||
| JP2013542261A5 (OSRAM) | ||
| JP2019525939A5 (OSRAM) | ||
| JP2008510770A5 (OSRAM) | ||
| JP2019505541A5 (OSRAM) | ||
| JP2011500758A5 (OSRAM) | ||
| JP2012532112A5 (OSRAM) | ||
| JP2017531038A5 (OSRAM) | ||
| JP2017524025A5 (OSRAM) | ||
| JP2009538910A5 (OSRAM) | ||
| JP2022017461A5 (OSRAM) |